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**Claire L. Wood**

**How would you explain the main findings of your paper to non-scientific family and friends?**

The mouse model commonly used in Duchenne muscular dystrophy (DMD) research is the X-linked muscular dystrophy (*mdx*) mouse, but it has significant limitations because the disease process is not as severe as in patients with DMD. Very few medications that are effective in the *mdx* mouse have shown to be useful in patients. Therefore, I have tested a new mouse model, the *mdx:Cmah^−/−^* mouse. This mouse is bred from the *mdx* mouse, but also has an additional gene deletion to make it more 'human' and therefore I had hoped that it would behave in a similar way to patients with DMD. I have looked, for the first time, at bone and growth in the *mdx:Cmah^−/−^* mouse and compared it to both the *mdx* and a healthy 'wild-type' mouse. Instead of finding impaired growth and skeletal development, I actually demonstrated that the *mdx:Cmah^−/−^* mouse shows catch-up growth and no evidence of impaired bone development.

> "In order to test new agents for use in DMD, we need to continue in our quest for the most appropriate animal model to use."

**What are the potential implications of these results for your field of research?**

Although it does not appear to be an appropriate model to investigate bone and growth in DMD, the *mdx:Cmah^−/−^* mouse may prove to be a useful model to study catch-up growth. In the meantime, in order to test new agents for use in DMD, we need to continue in our quest for the most appropriate animal model to use.

**What are the main advantages and drawbacks of the model system you have used as it relates to the disease you are investigating?**

The main advantage of the *mdx:Cmah^−/−^* mouse model that I have used is that it is genetically more similar to DMD than the traditional *mdx* mouse model and theoretically should therefore have reflected the disease course in DMD better than the *mdx* mouse. However, as I have demonstrated, the pattern of growth and bone development was not as expected.

> "I am in awe of the patience that my lab colleagues have and it has surprised me how much work goes into perfecting one technique in the laboratory."

**What has surprised you the most while conducting your research?**

This was the first time I have spent a concentrated period of time carrying out basic science research. It has been a huge learning curve for me and so different from my clinical career up until now. I am in awe of the patience that my lab colleagues have and it has surprised me how much work goes into perfecting one technique in the laboratory.

**Describe what you think is the most significant challenge impacting your research at this time and how will this be addressed over the next 10 years?**

I am currently investigating different anabolic agents to try and improve the bone and growth phenotype of steroid-treated boys with DMD. There is still no well-established small animal model that mimics DMD, and many of the compounds that have shown promise in the *mdx* mouse model have not translated into success at the clinical trial stage. This is a huge limitation when trying to re-purpose drugs. **Example of a calcein-labelled growth plate in a 3-week-old mouse.**

**What changes do you think could improve the professional lives of early-career scientists?**

I think that access to small research grants in order to continue research post-PhD and carry out pilot studies/pump-priming work prior to obtaining a larger fellowship is vital for early-career scientists, in order to be able to develop their own research interest and start to work independently.

**What\'s next for you?**

I have just been awarded an NIHR academic clinical lecturership at Newcastle to continue my research alongside finishing my clinical training to become a paediatric endocrinologist. I am excited to have dedicated research time to further my expertise in the field of bone and growth in paediatric endocrinology.
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